FOXO1 and cancer: Because the activity of FOXO1 is regulated at the post-translational level rather than through changes in transcription and is therefore hidden in RNA-seq data, the role of FOXO1 in cancer immunology and immunotherapy is likely to have been considerably underappreciated.